Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc (NASDAQ-CURX) is a Healthcare sector company in the Pharmaceuticals industry. The Curanex Pharmaceuticals Inc security is listed on NASDAQ as common stock, so it should be viewed as common equity in a company rather than a fund or debt instrument. Based on the available business description, the company is associated with pharmaceutical research and development focused on botanical or plant-derived treatments for inflammatory and related medical conditions. This overview reflects the security context of the listing and does not add details beyond the supplied classification and company description.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CURX
|
$5.67
|
29.0% Upside
|
Undervalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 13, 2026
|
1.4x
|
6.916 M
|
4.238 M
|
3.8%
|
6.0
|
115.4%
|
